ISPCiSpecimen Inc
ISPC
iSpecimen Inc8,942
Mkt Cap
$3.8MVolume
364.96M52W High
$3.1852W Low
$0.1257PE Ratio
-0.06ISPC Fundamentals
Price
$0.1281Prev Close
$0.1301Open
$0.20150D MA
$0.2407Beta
0.72Avg. Volume
18.61MEPS (Annual)
-$2.28P/B
0.35Rev/Employee
$275,571.14$5.41
iSpecimen Slashes Biospecimen Shipping Times by Up to 85%, Streamlining Global Research Supply Chain
iSpecimen (NASDAQ:ISPC) is making a significant operational leap, announcing a revamped logistics model that dramatically reduces the time it takes to deliver human biospecimens to researchers worldwide.
24-7 Market News·2d ago
Why Clearsign Technologies Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Clearsign Technologies Corp (NASDAQ: CLIR) shares rose 11.3% in pre-market trading after reporting better-than-expected quarterly results. Other gainers include iSpecimen Inc, Wellgistics Health Inc...
Benzinga·2d ago
iSpecimen Is Trending Overnight Here's Why ISPC Stock Surged 56% In The After-Hours Session
iSpecimen Inc. shares surge over 56% in after-hours trading after announcing faster shipping and expanded European sourcing, despite weak fourth-quarter results.read more...
Benzinga·2d ago
Nasdaq Microcap Soars After Unveiling AI Tool Designed to Accelerate Medical Research
Artificial intelligence is rapidly transforming the life sciences industry, particularly in areas where speed and precision can dramatically impact research outcomes. From drug discovery to clinical data analysis, AI-powered tools are increasingly helping scientists process vast amounts of information and connect critical research resources faster than ever before. One emerging application is the use of intelligent platforms to streamline access to human biospecimens, an essential component in developing diagnostics, therapies, and medical breakthroughs.Shares of iSpecimen Inc. (NASDAQ: ...
AllPennyStocks.com·30d ago
Nasdaq Microcap Soars After Unveiling AI Tool Designed to Accelerate Medical Research
Artificial intelligence is rapidly transforming the life sciences industry, particularly in areas where speed and precision can dramatically impact research outcomes. From drug discovery to clinical data analysis, AI-powered tools are increasingly helping scientists process vast amounts of information and connect critical research resources faster than ever before. One emerging application is the use of intelligent platforms to streamline access to human biospecimens, an essential component in developing diagnostics, therapies, and medical breakthroughs.Shares of iSpecimen Inc. (NASDAQ: ...
AllPennyStocks.com·30d ago
Nasdaq Microcap Soars After Unveiling AI Tool Designed to Accelerate Medical Research
Artificial intelligence is rapidly transforming the life sciences industry, particularly in areas where speed and precision can dramatically impact research outcomes. From drug discovery to clinical data analysis, AI-powered tools are increasingly helping scientists process vast amounts of information and connect critical research resources faster than ever before. One emerging application is the use of intelligent platforms to streamline access to human biospecimens, an essential component in developing diagnostics, therapies, and medical breakthroughs.Shares of iSpecimen Inc. (NASDAQ: ...
AllPennyStocks.com·30d ago
AI, Diagnostics and Next-Gen Materials Drive Innovation Push Across Emerging Growth Stocks
A wave of developments across emerging technology and life sciences companies underscores how artificial intelligence, advanced diagnostics, and next-generation biomaterials are converging to reshape several high-growth sectors. $ISPC, $AIFF, $KBLB, $BIAF, $ACXP, $KIDZ
24-7 Market News·30d ago
iSpecimen (ISPC) Stock Rockets 43% After Hours Here's Why It's Trending
iSpecimen shares surged nearly 43% in after-hours trading following the launch of its AI-powered Inventory Agent.read more...
Benzinga·1mo ago
iSpecimen Inc (ISPC) Stock Surged 42% After-Hours: Here's The News Behind The Move
iSpecimen shares jumped 42.4% after hours following a $5.5 million private placement, though the stock remains near its 52-week low.read more...
Benzinga·3mo ago
<
1
2
...
>